Rik Derynck, Ph.D.

Rik Derynck, Ph.D.

Akt-mTOR signaling in TGF-b responsiveness and Epithelial-Mesenchymal Transition


October 16, 2020, 11:00 a.m. to 12:00 p.m. [Add to calendar] In 144 days


Rik Derynck, Ph.D.

Departments of Cell/Tissue Biology and Anatomy
University of California, San Francisco


Fralin Biomedical Research Institute, R3012
2 Riverside Circle, Roanoke, VA 24016

This event will be webcast live

Epithelial-mesenchymal transition (EMT) is a normal differentiation process during development that enables epithelial cells to partially or completely repress epithelial junctions and reprogram gene expression, resulting in more motile and often more invasive cell behavior. EMT, which is generally thought of as a reversible process, allows the cells to reach new destinations and generate new cell populations. EMT is also repurposed pathologically during fibrosis and cancer progression, and allows carcinoma cells to disseminate, while additionally enabling the cells to acquire stem cell characteristics and cancer drug resistance. Studying the activities and signaling pathways of a secreted growth factor and cytokine, named transforming growth factor-beta (TGF-beta), we showed a long time ago that TGF-beta can induce EMT. Consistent with this notion and its known activities, increased TGF-beta signaling is now seen as a driver of fibrosis and cancer dissemination that leads to metastasis. Our research highlights the cooperation of two signaling pathways, Smad signaling and Akt-mTOR signaling, in the progression and completion of EMT, and illustrates that prolonged exposure of cancer cells stabilizes EMT, which stands in contrast to the general notion that EMT is always reversible. When compared to reversible EMT, stabilized EMT has increased stem cell properties and cancer stem cell properties that depend on mTOR signaling. The recognition of the roles of EMT in fibrosis and cancer, and the key role of TGF-beta as driver of the EMT process allow for therapeutic opportunities.

This Pioneers in Biomedical Research Seminar is presented by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Group.

Additional Details

This is a free event. The host is Fralin Biomedical Research Institute Cancer Group. For more information, please call 540-526-2002, or send an e-mail.

Map and Parking

This map shows where the Fralin Biomedical Research Institute is located in Roanoke, VA at 2 Riverside Circle.

Parking is available in the parking garage across the street.

Click the "Google" logo for a larger version.

Event Type